Pablog

Only about half the children who develop acute myelogenous leukemia will survive. A physician scientist, Dr. Stevens has identified an antibiotic that is extremely effective in the laboratory at killing AML or slowing it’s progression. With her Powered by Pablove funds, Dr. Steven will try and identify which children will derive the most benefit from […]

Neurofibromatosis type I (NF1), an inherited condition in children, affects one in every 3,000 individuals worldwide. Although benign in nature, in some cases, the slowly growing NF1-mutated nerve tumors can become malignant peripheral nerve sheath tumors (MPNST), killing 50% of the patients within five years. Dr. Wu’s Powered by Pablove research projects aim to unravel […]

All the way in Barcelona, Spain, Dr. Thais Armengue is studying a rare autoimmune condition called Opsoclonus-myoclonus Syndrome (OMS). With her Powered by Pablove funds, Dr. Armengue is using novel technical approaches to identify the specific antibodies involved in OMS, paving the way for a more thorough understanding of how the disease develops.    In […]

Osteosarcoma is among the most frequent primary malignant bone cancers in childhood and adolescence. A scientist by training, Dr. Lee is studying a genetic mutation in the p53 tumor suppressor gene to help illuminate how it contributes to the development of osteosarcoma. A successful Powered by Pablove research project will aid greatly in diagnosis or […]

As a scientific researcher Dr. Huff’s work is focused on tumors of the kidneys called Wilms Tumor. There is a genetic predisposition tied to Wilms Tumor and in this Powered by Pablove Research project, Dr. Huff is studying an agent she hopes will counter the effects of that genetic predisposition to prevent the growth of […]